Steve Gullans

Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.

Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

Navigation Sciences, Inc. is a private company that specializes in developing the NaviSci™ system, which provides real-time margin measurement for precision cancer surgery. The company is based in Brookline, MA. The system is designed to address the growing need to locate and remove lung and other soft tissue cancers. The company was founded in 2017 by Jayender Jagadeesan, Alan D. Lucas, and Raphael Bueno. Alan D. Lucas has been the CEO since 2017.

Navigation Sciences, Inc. is a private company that specializes in developing the NaviSci™ system, which provides real-time margin measurement for precision cancer surgery. The company is based in Brookline, MA. The system is designed to address the growing need to locate and remove lung and other soft tissue cancers. The company was founded in 2017 by Jayender Jagadeesan, Alan D. Lucas, and Raphael Bueno. Alan D. Lucas has been the CEO since 2017.

N-of-One, Inc. engages in the provision of clinical evidence to translate molecular test results into therapeutic options. It offers clinical interpretation, precision insights and clinical trial match solutions. It serves to commercial laboratories, hospital laboratories and medicine programs. The company was founded by Jennifer Levin Carter in 2008 and is headquartered in Lexington, MA.

Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.

Navigation Sciences, Inc. is a private company that specializes in developing the NaviSci™ system, which provides real-time margin measurement for precision cancer surgery. The company is based in Brookline, MA. The system is designed to address the growing need to locate and remove lung and other soft tissue cancers. The company was founded in 2017 by Jayender Jagadeesan, Alan D. Lucas, and Raphael Bueno. Alan D. Lucas has been the CEO since 2017.

Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

RxGen, Inc. operates as a translational research company. It specializes in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development. The company was founded by Christopher M. Stanley, Steven R. Gullans and Harry H. Penner, Jr. and is headquartered in Manhattan Beach, CA.

N-of-One, Inc. engages in the provision of clinical evidence to translate molecular test results into therapeutic options. It offers clinical interpretation, precision insights and clinical trial match solutions. It serves to commercial laboratories, hospital laboratories and medicine programs. The company was founded by Jennifer Levin Carter in 2008 and is headquartered in Lexington, MA.

Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

N-of-One, Inc. engages in the provision of clinical evidence to translate molecular test results into therapeutic options. It offers clinical interpretation, precision insights and clinical trial match solutions. It serves to commercial laboratories, hospital laboratories and medicine programs. The company was founded by Jennifer Levin Carter in 2008 and is headquartered in Lexington, MA.

N-of-One, Inc. engages in the provision of clinical evidence to translate molecular test results into therapeutic options. It offers clinical interpretation, precision insights and clinical trial match solutions. It serves to commercial laboratories, hospital laboratories and medicine programs. The company was founded by Jennifer Levin Carter in 2008 and is headquartered in Lexington, MA.

Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015.

Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.

Excel Medical Ventures LLC (Excel Medical Ventures) is a venture capital firm founded in 2004 by Steven R. Gullans. The firm is headquartered in Boston, Massachusetts.

Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015.

Excel Medical Ventures LLC (Excel Medical Ventures) is a venture capital firm founded in 2004 by Steven R. Gullans. The firm is headquartered in Boston, Massachusetts.

Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

Excel Medical Ventures LLC (Excel Medical Ventures) is a venture capital firm founded in 2004 by Steven R. Gullans. The firm is headquartered in Boston, Massachusetts.

N-of-One, Inc. engages in the provision of clinical evidence to translate molecular test results into therapeutic options. It offers clinical interpretation, precision insights and clinical trial match solutions. It serves to commercial laboratories, hospital laboratories and medicine programs. The company was founded by Jennifer Levin Carter in 2008 and is headquartered in Lexington, MA.

N-of-One, Inc. engages in the provision of clinical evidence to translate molecular test results into therapeutic options. It offers clinical interpretation, precision insights and clinical trial match solutions. It serves to commercial laboratories, hospital laboratories and medicine programs. The company was founded by Jennifer Levin Carter in 2008 and is headquartered in Lexington, MA.

Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.

Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.